Biogen (United States)

Biogen (United States)

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Biogen (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

52%


Total
Publications

6.8K


Total Open
Publications

3.5K


Total
Citations

341K


Open Access
Percentage

52%


Total
Publications

6.8K


Total Open
Publications

3.5K


Total
Citations

341K

Wikipedia

Website

download

Breakdown

18% 24% 10% 48%

Publisher Open

18%

Both

24%

Other Platform Open

10%

Closed

48%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300350400450Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

28%OA Journal

OA Journal 28%

797

Hybrid 41%

1.1K

No Guarantees 31%

872

Other Platform Open

Domain 80%

1.9K

Institution 21%

496

Other Internet 14%

330

Preprint 13%

310

Public 8%

186

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
1.9K
Europe PMC
Domain
1K
DOI
Other Internet
217
Semantic Scholar
Public
143
bioRxiv
Preprint
143
University College London - UCL Discovery
Institution
95
medRxiv
Preprint
74
Figshare
Public
60
University of Cambridge - Apollo
Institution
57
Research Square
Preprint
54
1 / 20

Data updated 7 April 2025

Share

Share

Share